Public listing
Point-of-care coagulation platform exploring acquisition or strategic partnership options
A diagnostics platform with real market relevance and a live mandate to explore strategic alternatives before the next scale phase.
AcquisitionStrategic PartnershipInvestment Recapitalization
Single Product
Lab
Publication controls
How public sharing is handled
Contact details remain private by default. Fields marked “Prefer not to publish” stay muted so the listing still feels complete without exposing sensitive information.
Organization namePrefer not to publish
WebsitePrefer not to publish
Exact countryEurope
Contact detailsPrivate by default
Listing owner and contact
Build trust up front. Contact fields are collected for operations and stay private by default unless you explicitly choose otherwise.
Organization namePrefer not to publish
Organization typeAdvisor
CountryEurope
WebsitePrefer not to publish
LinkedInNot provided
Primary contact namePrivate by default
Primary contact rolePrivate by default
Primary contact emailPrivate by default
Primary contact phonePrivate by default
Represented by advisorYes
Advisor firm nameOrion Diagnostics Group
Relationship to the opportunityAdvisor
Opportunity basics
Define what the listing is and why it deserves attention.
Public-facing opportunity headlinePoint-of-care coagulation platform exploring acquisition or strategic partnership options
Internal listing titleNot provided
CategoryDiagnostics
SubcategoryPoint-of-care testing
Regulated product typePoint-of-care coagulation platform
Device type / product familyNot provided
Broad intended useNear-patient coagulation testing platform for outpatient, decentralized, and specialist settings.
Care setting / use settingLab
Asset scopeSingle Product
Opportunity summaryA diagnostics platform with real market relevance and a live mandate to explore strategic alternatives before the next scale phase.
What makes this opportunity attractiveThis is a credible platform with several plausible strategic paths rather than a one-track distressed listing.
Top 3-5 highlightsStrategic options mandate already active
Diagnostics category with decentralized-care relevance
Could fit investor-backed or strategic owners
Multiple transaction shapes remain open
Deal structure
Be explicit about the structures that make sense and who the right counterparty is.
Deal type(s) soughtacquisition, strategic_partnership, investment_recapitalization
Preferred primary deal typeStrategic Partnership
Open to alternativesNot provided
Exclusivity availableNot provided
Exclusivity scopeNot provided
Ideal partner / counterparty typediagnostics strategic, focused investor, commercialization partner
Deal urgencyNot provided
Preferred timelineNot provided
Geography and rights
This helps route the listing to the right regional or rights-focused counterparties.
Organization geographyNot provided
Jurisdictions relevant to the productNot provided
Markets currently coveredNot provided
Markets availableNot provided
Rights availability by regionNot provided
Rights retained internallyNot provided
Rights already granted elsewhereNot provided
Target geographies for this opportunityUnited States and Europe
Preferred partner geographiesNot provided
Regulatory and market status
Keep this high-level, structured, and strong enough to give the listing credibility.
Regulatory jurisdictionsNot provided
Current regulatory / market status by jurisdictionNot provided
Approval / clearance / registration typeNot provided
High-level regulatory summaryUS and EU pathways are established.
Commercialization readinessNot provided
Any active sales marketsNot provided
Market-readyNot provided
Under-commercializedNot provided
Rights available because not fully scaled internallyNot provided
Commercial context
This is where the listing becomes compelling instead of generic.
Commercialization stageestablished_but_under_scaled
Current traction levelNot provided
Distribution footprint todayNot provided
Channel model todayNot provided
Current commercialization challengeThe question is strategic scale and ownership support, not product legitimacy.
Why nowExploratory Strategic Options
Ideal next stepNot provided
What kind of partner would unlock the most valueNot provided
Opportunity quality and counterparty fit
These fields are what make the public teaser feel real, specific, and worth responding to.
Why the right counterparty should careNot provided
Strongest non-confidential selling pointsNot provided
What makes the product differentiatedNot provided
What kind of company is the best fitNot provided
Better suited forNot provided
Inbound only or active matchingNot provided
Optional commercial detail
Only share these if they help without overexposing the listing.
Revenue bandNot provided
Pricing modelNot provided
Installed base / active customersNot provided
Channel relationshipsNot provided
Existing distribution arrangementsNot provided
Manufacturing readinessNot provided
Inventory availableNot provided
Product line separable from businessNot provided
Service / support requirement levelNot provided
Attachments and supporting material
Optional non-confidential URLs can strengthen a public teaser quickly.
Teaser image URLNot provided
Non-confidential deck URLNot provided
One-pager URLNot provided
Brochure URLNot provided
Product sheet URLNot provided
Commercial overview URLNot provided
Summary memo URLNot provided
Other non-confidential file URLsNot provided